Population
Geriatric patients (typically aged >65 or >70-80 years) with heart failure
Design
Editorial
Key result
All heart failure therapies, from drugs to devices, are recommended in geriatric patients, though treatment should be personalized considering comorbidities and frailty.
Authors
Loading...
Endorses HF therapies in geriatrics with frailty-based personalization; leaves open dedicated trials in this population.
Standard heart failure therapies remain effective and recommended in geriatric patients, but require careful personalization and monitoring due to comorbidities and polypharmacy.
Abdullah Al Shafi Majumder (2022) conducted an editorial in Heart failure. Heart failure therapies was evaluated. All heart failure therapies, from drugs to devices, are recommended in geriatric patients, though treatment should be personalized considering comorbidities and frailty.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: